Market evolution: Caprolactam (CN 293371) — 2015–2025
Introduction
This report analyzes the evolution of the European Union's trade in epsilon-caprolactam (Customs code 293371) from 2015 to 2025. The data reveals a fundamental transformation of the EU's position in the global market for this key chemical intermediate, which is primarily used in the production of nylon-6. Over the decade, the EU underwent a dramatic shift from being a major net exporter to becoming a significant net importer. This report examines the core dynamics behind this structural change.
The Collapse of EU Export Dominance
The most striking trend in the EU caprolactam market is the near-total evaporation of its export trade. The EU moved from a position of overwhelming trade surplus to one of marginal balance, driven by a combination of collapsing export volumes and a surge in imports.
Exports plummeted while imports surged exponentially
Between 2015 and 2025, EU exports of caprolactam experienced a catastrophic decline, while imports grew from a negligible base.
| Metric | 2015 (First) | 2025 (Last) | Percentage Change |
|---|---|---|---|
| Export Value (EUR) | €486.4 million | €25.1 million | -94.8% |
| Export Quantity (t) | 353,340 | 16,095 | -95.4% |
| Import Value (EUR) | €99,046 | €23.3 million | +23,474.4% |
| Import Quantity (t) | 37.7 | 18,365 | +48,620.9% |
The EU's trade balance swung from a surplus of approximately €486 million in 2015 to a surplus of just €1.8 million in 2025.
Traditional export markets were lost, and new import sources emerged
The collapse was geographically broad, with shipments to major Asian destinations ceasing entirely. Concurrently, Russia and the United States became critical import suppliers.
Top 2025 Export Partners vs. 2015 (Value)
| Partner | 2015 Value (EUR) | 2025 Value (EUR) | Change |
|---|---|---|---|
| China | €74.8 million | €26,845 | -100.0% |
| Taiwan | €103.4 million | €117 | -100.0% |
| South Korea | €76.7 million | €505 | -100.0% |
| Switzerland | €48.9 million | €11.0 million | -77.6% |
| Türkiye | €19.3 million | €3.9 million | -79.7% |
Top 2025 Import Partners vs. 2015 (Value)
| Partner | 2015 Value (EUR) | 2025 Value (EUR) | Change |
|---|---|---|---|
| Russian Federation | €99,239 | €34.5 million | +34,685.4% |
| China | €7,360 | €14.5 million | +196,553.4% |
| United States | €1,731 | €8.8 million | +509,461.4% |
| South Korea | €373 | €975,840 | +261,519.3% |
For more details, see the top partners by value.
Declining Production and Shifting Specialization
The trade collapse is underpinned by a significant contraction in EU domestic production and a reshuffling of internal specialization patterns among Member States.
Domestic production contracted sharply
EU caprolactam production volumes fell by nearly half over the period, indicating reduced capacity or competitiveness.
| Production Metric | 2015 (First) | 2025 (Last) | Percentage Change |
|---|---|---|---|
| Volume (kg) | 901,148,130 | 484,453,391 | -46.2% |
| Value (EUR) | €5.94 billion | €4.67 billion | -21.4% |
Export concentration increased as the market shrank
While the overall EU export concentration (HHI) increased, this reflects a smaller, more concentrated pool of exporters rather than market strength. Conversely, import concentration also rose, highlighting growing reliance on a few suppliers.
| Flow | 2015 HHI (Value) | 2025 HHI (Value) | Change |
|---|---|---|---|
| Imports | 4,431 | 5,269 | +18.9% |
| Exports | 1,355 | 2,722 | +100.9% |
Belgium remained the most specialized producer, but all major exporters declined
Specialization data shows that Belgium maintained a high Revealed Symmetric Comparative Advantage (RSCA) score in 2025, but the export performance of all key EU Member States collapsed.
| EU Member State | 2025 RSCA | 2015→2025 Export Value Change |
|---|---|---|
| Belgium | 0.81 | -89.6% |
| Netherlands | 0.06 | -94.6% |
| Germany | n/a | -58.4% |
| Poland | n/a | -99.6% |
For full specialization details, see the most specialised reporters.
Rising Volatility and Strategic Vulnerability
The transition to a net-import position has introduced new dynamics of price volatility and increased the EU's strategic vulnerability to external supply shocks.
Significant price and supply shocks characterized the period
Analysis of volatility identifies several abnormal events that impacted the market, including a complete collapse of supply from a key partner.
| Shock Event | Flow | Period | Shift | Abnormality |
|---|---|---|---|---|
| Supply collapse from China | Exports | 2025 | -99.3% | 3.5 |
| Price spike for exports to Switzerland | Exports | 2022 | +81.0% | 4.0 |
| Price spike for exports to Türkiye | Exports | 2017 | +36.3% | 3.7 |
The EU transformed from a super-exporter to a net importer
The shift is most starkly captured by the Net Import Reliance indicator, which moved from an extreme negative value (indicating massive net exports) to a positive 77.6% (indicating substantial net imports).
| Metric | 2015 (First) | 2025 (Last) | Change |
|---|---|---|---|
| Net Import Reliance % | -6,085.5% | +77.6% | 101.3% |
This transformation is further evidenced by the declining Trade Intensity (from 140.3% to 110.4%) and the sustained, though slightly declining, Export Propensity (168.7% to 163.7%), confirming that while the EU still exports significantly relative to its production, the scale of its production has diminished.
Conclusion
Over the 2015–2025 period, the EU caprolactam market underwent a profound structural reorientation. The era of European dominance as a global supplier effectively ended, evidenced by a 95% decline in exports and a 46% fall in domestic production. The EU's role reversed, becoming a net importer reliant on supplies from Russia, China, and the United States. This shift has concentrated import sources and introduced new price volatility and supply risks, fundamentally altering the strategic landscape for the EU's nylon value chain. The data points to a competitive challenge that has reshaped regional trade flows and reduced the bloc's self-sufficiency in this critical chemical.